Vident Investment Advisory, LLC Morpho Sys Ag Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.95 - $23.95 $1.11 Million - $1.41 Million	-58,814 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$24.81 - $30.33 $381,677 - $466,596	15,384 Added 35.42%	58,814 $1.67 Million
Q3 2020 Nov 12, 2020	SELL	$30.28 - $35.72 $87,690 - $103,445	-2,896 Reduced 6.25%	43,430 $1.36 Million
Q2 2020 Jul 17, 2020	BUY	$24.08 - $33.35 $138,146 - $191,328	5,737 Added 14.13%	46,326 $1.47 Million
Q1 2020 May 12, 2020	SELL	$18.86 - $37.36 $52,732 - $104,458	-2,796 Reduced 6.44%	40,589 $997,000
Q4 2019 Feb 11, 2020	SELL	$26.07 - $36.32 $346,861 - $483,237	-13,305 Reduced 23.47%	43,385 $1.55 Million
Q3 2019 Nov 13, 2019	SELL	$24.18 - $31.58 $39,171 - $51,159	-1,620 Reduced 2.78%	56,690 $1.56 Million
Q2 2019 Aug 12, 2019	BUY	$23.24 - $26.76 $70,672 - $81,377	3,041 Added 5.5%	58,310 $1.41 Million
Q1 2019 May 08, 2019	SELL	$22.55 - $29.84 $32,787 - $43,387	-1,454 Reduced 2.56%	55,269 $1.26 Million
Q4 2018 Feb 14, 2019	SELL	$21.96 - $31.02 $552,908 - $781,021	-25,178 Reduced 30.74%	56,723 $1.44 Million
Q3 2018 Nov 14, 2018	SELL	$26.64 - $35.66 $156,430 - $209,395	-5,872 Reduced 6.69%	81,901 $2.19 Million
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $2.21 Million - $2.69 Million	87,773 New	87,773 $2.66 Million

1.84M

79.8K

688K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.